Dermatology Drug Developer Hits Ch. 11 With Sale Plan

By Yun Park · November 20, 2023, 5:12 PM EST

Dermatology treatment developer Timber Pharmaceuticals Inc. filed for Chapter 11 in Delaware bankruptcy court, saying it wants to sell its assets to a failed pre-bankruptcy merger partner....

To view the full article, register now.